VR技术

Search documents
科技赋能中国文旅产业:从体验革新到场景重构
Zhong Guo Xin Wen Wang· 2025-09-12 08:03
科技赋能中国文旅产业:从体验革新到场景重构 中新社武汉9月12日电 题:科技赋能中国文旅产业:从体验革新到场景重构 中新社记者 张芹 坐在划船机里戴上VR头盔,化身"船长"畅游天津海河;身着汉服的机器人与真人舞者默契联动,演绎 太极;在直径12米的巨型球形屏幕里沉浸式感受千年应县木塔精巧的榫卯结构…… 正在武汉举行的2025中国文化旅游产业博览会上,科技与文旅融合的丰硕成果得以全方位展现。 本届博览会中,机器人的广泛应用成为一大亮点。穿梭于各个展区可以看到,机器人不仅承担部分会场 讲解、迎宾导览等工作,还化身"乐手"与"舞者"参与演出。 9月12日上午,中国文化旅游产业博览会在武汉开幕。图为人形机器人与真人舞者共同完成武汉展 区开场演出。(主办方供图) 在武汉展区,5台由当地科技企业打造的人形机器人,以流畅的肢体动作、精准的节奏把控完成了精彩 的开场舞表演。舞台背景则巧妙融入黄鹤楼、光谷星河、空轨列车等元素,让科技演绎与城市文化深度 交融。 一台名为"寂静"的机器人,在现场用架子鼓演绎了《我和我的祖国》等多首曲目,引得众人围观。"我 们通过先进的算法技术与音乐编程,赋予机器人媲美专业乐手的演奏能力。"该机器人 ...
医疗健康领域投融资日报(6月5日):科伦博泰获得2.5亿美元战略投资
Sou Hu Cai Jing· 2025-06-09 09:28
Summary of Key Points Core Viewpoint - The report highlights a total of 28 financing events disclosed on June 5, 2025, involving 16 domestic companies and 12 foreign companies, with a total financing amount of approximately 12.38 billion RMB. The healthcare sector leads in the number of events, while the automotive sector leads in financing amount. Group 1: Domestic Healthcare Sector - The domestic healthcare sector saw 4 companies receiving funding, totaling approximately 1.92 billion RMB [1] - Kelun-Biotech received a strategic investment of 250 million USD, ranking in the top 10% of all strategic investments this year [1] - Qiyu Biotech completed a C round financing of several hundred million RMB, with the investor being Yifeng Capital [1] - Ruizhou Biotech secured A+ round financing of several tens of millions RMB, ranking in the top 50% of all A+ round financings this year [1] - Sipure completed an angel round financing of 200 million RMB, ranking in the top 1% of all angel round financings this year [1] Group 2: Foreign Healthcare Sector - The foreign healthcare sector reported 2 companies being acquired and 1 company receiving funding, totaling approximately 410 million RMB [2] - Focal Medical was acquired by Continuity Biosciences, a US-based biopharmaceutical service provider [2] - Biocrates Life Sciences was acquired by Bruker, an Australian analytical reagent kit developer [2] - Holoeyes completed B+ round financing of 1.6 million USD, focusing on VR organ model technology [2]